Posted on 5/14/20
Is Bristol Myers Squibb Losing Its Edge As A Growth Stock?
Despite soundly beating revenue forecasts last quarter, Bristol Myers Squibb (NYSE:BMY) was forced to delay its chimeric antigen receptor T-cell (CAR-T) immunotherapy after the Food and . . .
Posted on 5/14/20
Bristol Myers Squibb Receives a 'Refuse to File' Letter for an Experimental Cancer Therapy on a Deadline
Critically ill patients with multiple myeloma will need to wait a lot longer for an experimental new cancer therapy from Bristol Myers Squibb (NYSE:BMY) and bluebird . . .
Posted on 5/14/20
Thermo Fisher to Turn Coronavirus Antibody Testing on Its Head
Thermo Fisher Scientific (NYSE:TMO) is expanding its response to the coronavirus pandemic with a little help from some friends. The Mayo Clinic and WuXi Diagnostics will . . .
Posted on 5/13/20
Insulet Corp. Prices $500M Public Offering of Common Stock
ACTON, Mass.--(BUSINESS WIRE)--Insulet Corporation (NASDAQ: PODD), a global leader in tubeless insulin pump technology with its Omnipod® Insulin Management System (Omnipod System), today announced the pricing . . .
Posted on 5/13/20
PM Pediatrics Hits Milestone 10,000 COVID-19 PCR and Antibody Tests Administered to Kids and Families
PM Pediatrics, the nation’s largest provider of pediatric urgent care, today announced it has conducted more than 10,000 COVID-19 PCR and antibody tests in the last . . .
Posted on 5/13/20
Drug Use by State: 2020’s Problem Areas – WalletHub Study
With the stress of social distancing leading to drug use relapses or overdoses, and SAMHSA’s National Prevention Week in full swing, the personal-finance website WalletHub today . . .
Posted on 5/13/20
CVS Is Healthier than Its Valuation Indicates
Wall Street's first quarter earnings results suggest financial guidance and forecasting is now voluntary. With many reports still to come, over 20% of publicly traded companies . . .
Posted on 5/12/20
Syndax Closes Public Offering of Common Stock
Syndax Pharmaceuticals, Inc. (Nasdaq: SNDX), a clinical-stage biopharmaceutical company developing an innovative pipeline of cancer therapies, today announced the closing of its previously announced underwritten public offering . . .
Posted on 5/12/20
Abveris Announces Human Antibody Discovery Partnership with Nkarta
CANTON, Mass.--(BUSINESS WIRE)--Abveris, Inc. announced today that it has entered into an antibody discovery partnership with Nkarta, Inc. for the discovery of fully-human monoclonal antibodies to support . . .
Posted on 5/12/20
Akebia Therapeutics Prices Upsized Public Offering of Common Stock
Akebia Therapeutics, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, today announced the pricing of . . .
Posted on 5/12/20
3PRE Technology Brings Advancements In Antimicrobial Safety To Medical Device Industry
In an era of heightened awareness over viruses and contaminants, Advancing Medical Innovations (AMI) announced its client Performance Compounds Inside (PCI)'s novel 3PRE Technology can bring . . .
Posted on 5/12/20
Skyhawk Therapeutics Announces Expansion of its Collaboration Agreement with Merck
Skyhawk Therapeutics, Inc. today announced that it has expanded its strategic collaboration with Merck, known as MSD outside the United States and Canada, to discover, develop and . . .
Posted on 5/12/20
Yale New Haven Health Partners with Capsule Technologies
Yale New Haven Health System (YNHHS), the largest health system in Connecticut, has deployed Capsule's Ventilated Patient Surveillance (VPS) workstation to deliver safe and effective patient . . .
Posted on 5/12/20
HealthcareSource Partners With Fusion Marketing Group
HealthcareSource®, the leading provider of talent management solutions for the healthcare industry, today announced the expansion of its recruitment marketing offering by partnering with Fusion Marketing . . .
Posted on 5/12/20
Dyno Therapeutics Announces Presentations at 2020 American Society of Gene and Cell Therapy Conference
Dyno Therapeutics, a biotechnology company applying artificial intelligence (AI) to gene therapy, today announced two presentations and a poster at the American Society of Gene and . . .
Posted on 5/12/20
Medical Device Maker Ambu Launches New Single-Use Cystoscope for Improved Workflow and Enhanced Productivity Benefits
Ambu Inc., a rapidly growing medical device maker and pioneer of sterile, single-use endoscopes, introduced today a new single-use cystoscope. The Ambu® aScope™ 4 Cysto will . . .
Posted on 5/12/20
scPharmaceuticals Inc. Reports First Quarter 2020 Financial Results and Provides Business Update
BURLINGTON, Mass.--(BUSINESS WIRE)--scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, . . .
Posted on 5/12/20
Novanta Announces Financial Results for the First Quarter 2020
BEDFORD, Mass.--(BUSINESS WIRE)--Novanta Inc. (Nasdaq: NOVT), a trusted technology partner to medical and advanced technology equipment manufacturers, today reported financial results for the first quarter 2020.First . . .
Posted on 5/12/20
Dynatrace Reports Fourth Quarter and Full Year Fiscal Year 2020 Financial Results
WALTHAM, Mass.--(BUSINESS WIRE)--Dynatrace (NYSE: DT), the market-leading software intelligence provider, purpose-built for dynamic multi-clouds, today released financial results for the fourth quarter of its fiscal 2020 . . .
Posted on 5/12/20
States with the Most Vulnerable Populations to Coronavirus – WalletHub Study
With nearly 75 percent of patients hospitalized for coronavirus being at least 50 years old, and around 90 percent having pre-existing conditions, it’s important for states . . .
Posted on 5/12/20
Bristol Myers Squibb Offers bluebird bio a $200 Million Royalty Buyout
A couple of complex collaboration agreements that Bristol Myers Squibb (NYSE:BMY) inherited from Celgene are about to get a lot simpler. The big pharma is going . . .
Posted on 5/12/20
Takeaways From the Berkshire Hathaway Annual Meeting
In this episode of MarketFoolery, Chris Hill and Motley Fool Chief Investment Officer Andy Cross take a look at some business headlines. Their topics include Berkshire . . .
Posted on 5/12/20
Mevion Medical Systems Signs Agreement to Bring Compact Proton Therapy to Texas
LITTLETON, Mass.--(BUSINESS WIRE)--Mevion Medical Systems announced today that it has signed a letter of intent to provide the MEVION S250i Proton Therapy System® with HYPERSCAN® Pencil . . .
Posted on 5/12/20
Dyno Therapeutics Emerges from Stealth to Transform Gene Therapy
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Dyno Therapeutics, Inc., a biotechnology company applying artificial intelligence (AI) to gene therapy, today announced the company’s launch from stealth mode with its proprietary . . .
Posted on 5/12/20
Infinity Pharmaceuticals Provides Company Update
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) today announced its first quarter 2020 financial results and provided an update on the Company, including its first quarter . . .

